Imaging the brain marijuana receptor: Development of a radioligand that binds to cannabinoid CB1 receptors in vivo

Journal of Neurochemistry

Volumn 70, Issue 1, 1998, Pages 417-423

  Gatley, S John ^a   Lan, Ruoxi ^c   Volkow, Nora D ^a,b   Pappas, Naomi ^a   King, Payton ^a   Wong, Christopher T ^a   Gifford, Andrew N ^a   Pyatt, Beatrice ^a   Dewey, Stephen L ^a   Makriyannis, Alexandros ^c  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Cannabinoid CB1 receptors; Marijuana; Radionuclide imaging; 123I AM281.

Indexed keywords

CANNABINOID RECEPTOR; RADIOLIGAND; TETRAHYDROCANNABINOL;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; LIGAND BINDING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR BINDING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALIA; CANNABIS SATIVA; PAPIO HAMADRYAS;

EID: 0031972639     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70010417.x     Document Type: Article

References (44)

1. Block R. I. and Ghoneim M. M. (1993) Effects of chronic marijuana use on human cognition. Psychopharmacology (Berlin) 110, 219-228.
2. Block R. I., Farinpour R., and Braverman K. (1992) Acute effects of marijuana on cognition: relationships to chronic effects and smoking techniques. Pharmacol. Biochem. Behav. 43, 907-917.
3. Chait L. D. and Pierri J. (1992) Effects of smoked marijuana on human performance: a critical review, in Marijuana/Cannabinoids: Neurobiology and Neurophysiology (Murphy L. and Bartke A., eds), pp. 387-423. CRC Press, Boca Raton, Florida.
4. 18F-delta 8-THC. Pharmacol. Biochem. Behav. 40, 503-507.
5. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3110.
6. Deahl M. (1991) Cannabis and memory loss. Br. J. Addict. 86, 249-252.
7. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
8. 11C]Benztropine as a possible muscarinic cholinergic receptor ligand for use in PET. J. Nucl. Med. 30, 741-748.
9. Fowler J. S., Volkow N. D., Wolf A. P., Dewey S. L., Schlyer D. J., and MacGregor R. R. (1989) Mapping cocaine binding sites in human and baboon brain in vivo. Synapse 4, 371-377.
10. Gatley S. J. and Volkow N. D. (1997) Studies of the brain cannabinoid system using positron emission tomography, in Drug Abuse in the Decade of the Brain (Fay C., ed), pp. 127-138. IOS Press, Amsterdam.
11. Gatley S. J., Gifford A. N., Volkow N. D., Lan R., and Makriyannis A. (1996) Iodine-123 labeled AM251: a radioiodinated ligand which binds in vivo to the mouse brain CB1 cannabinoid receptor. Eur. J. Pharmacol. 307, 301-308.
12. Gatley S. J., Lan R., Volkow N. D., and Makriyannis A. (1997) Binding of the non-classical cannabinoid CP 55,940 and the diarylpyrazole AM251 to rodent cannabinoid receptors. Life Sci. 61, 191-197.
13. Gerostamoulos J. and Drummer O. H. (1993) Incidence of psychoactive cannabinoids in drivers killed in motor vehicle accidents. J. Forensic Sci. 38, 649-656.
14. Gifford A. N. and Ashby C. R. (1996) Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. J. Pharmacol. Exp. Ther. 277, 1431-1436.
15. Gifford A.N., Samiian L., Gatley S. J., and Ashby C. R. (1997) Examination of the effect of the cannabinoid receptor agonist, CP 55,940 on electrically evoked transmitter release from rat brain slices. Eur. J. Pharmacol. 324, 187-192.
16. Glass M., Faull R. L. M., and Dragunow M. (1993) Loss of cannabinoid receptors in the substantia nigra in Huntington's disease. Neuroscience 56, 523-527.
17. Glass M., Dragunow M., and Faull R. L. M. (1997) Cannabinoid receptors in the human brain - a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77, 299-318.
18. Heishman S. J., Huestis M. A., Henningfield J. E., and Cone E. J. (1990) Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures. Pharmacol. Biochem. Behav. 37, 561-565.
19. Herkenham M., Lynn A. B., Little M. D., Johnson M. R., Melvin L. S., DeCosta B. R., and Rice K. C. (1990) Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA 87, 1932-1936.
20. Hollister L. E. (1986) Interactions of cannabis with other drugs in man. NIDA Res. Monogr. 68, 110-116.
21. Jansen E. M., Haycock D. A., Ward S. J., and Seybold V. S. (1992) Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res. 575, 93-102.
22. Lan R., Gatley S. J., and Makriyannis A. (1996) Preparation of iodine-123 labeled AM251, a potential SPECT radioligand for the brain cannabinoid CB1 receptor. J. Labeled Compounds 38, 875-881.
23. Leirer V. O., Yesavage J. A., and Morrow D. G. (1991) Marijuana carry-over effects on aircraft pilot performance. Aviat. Space Environ. Med. 62, 221-227.
24. Martin B. R. (1995) Marijuana, in Psychopharmacology: The Fourth Generation of Progress (Bloom F. E. and Kupfer D. J., eds), pp. 1757-1765. Raven Press, New York.
25. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C., and Bonne T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
26. Munro S., Thomas K. L., and Abu-Shaar M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
27. Perez-Reyes M., Hicks R. E., Bumberry J., Jeffcoat A. R., and Cook C. E. (1988) Interactions between marijuana and ethanol: effects on psychomotor performance. Alcohol. Clin. Exp. Res. 12, 268-276.
28. Richfield E. K. and Herkenham M. (1994) Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Ann. Neurol. 36, 577-584.
29. Rinaldi-Carmona M., Barth F., Heaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Neliat G., Caput D., Ferrara P., Soubrie P., Breliere J. C., and Lefur G. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350, 240-244.
30. 3H]SR141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain. Life Sci. 58, 1239-1247.
31. Schwartz R. H., Gruenewald P. J., Klitzner M., and Fedio P. (1989) Short-term memory impairments in cannabis-dependent adolescents. Am. J. Dis. Child. 143, 1214-1219.
32. Smith P. B., Compton D. R., Welch S. P., Razdan R. K., Mechoulam R., and Martin B. R. (1994) The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270, 219-227.
33. Solowij N. (1995) Do cognitive impairments recover following cessation of cannabis use? Life Sci. 56, 23-24.
34. Solowij N., Michie P. T., and Fox A. M. (1995) Differential impairments of selective attention due to frequency and duration of cannabis use. Biol. Psychiatry 37, 731-739.
35. Som P., Sacker D. F., and Oster Z. H. (1995) Quantitative whole body autoradiography, in Applications in Radiopharmaceutical and Drug Research. Autoradiography and Correlative Imaging, pp 149-166. Academic Press, San Diego.
36. 3H]11-OH-delta 9-THC-DMH. J. Pharmacol. Exp. Ther. 263, 1383-1390.
37. 18F-2-deoxy-2-fluoro-D-glucose. Psychiatr. Res. 40, 69-80.
38. Volkow N. D., Gillespie H., Tancredi L., and Hollister L. (1995) The effects of marihuana in the human brain measured with regional brain glucose metabolism, in Sites of Drug Action in the Human Brain (Biegon A. and Volkow N. D., eds), pp. 75-86 CRC Press, Boca Raton, Florida.
39. Volkow N. D., Gillespie H., Mullani N., Tancredi L., Grant C., Valentine A., and Hollister L. (1996) Brain glucose-metabolism in chronic marijuana users at base-line and during marijuana intoxication. Psychiatry Res. Neuroimaging 67, 29-38.
40. Volkow N. D., Wang G. J., Fischman M. W., Foltin R. W., Fowler J. S., Abumrad N. N., Vitkun S., Logan J., Gatley S. J., Pappas N., Hitzemann R., and Shea C. E. (1997) Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386, 827-830.
41. Welch M. J., Chi D. Y., Mathias C. J., Kilbourn M. R., Brodack J. W., and Katzenellenbogen J. A. (1986) Biodistribution of N-alkyl and N-fluoroalkyl derivatives of spiroperidol: radiopharmaceuticals for PET studies of dopamine receptors. Appl. Radial. Isotopes 13, 523-526.
42. Westlake T. M., Howlett A. C., Bonner T. I., Matsuda L. A., and Herkenham M. (1994) Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience 63, 637-652.
43. Yesavage J. A., Leirer V. O., Ditman J., and Hollister L. E. (1985) Carry-over effects of marijuana intoxication on aircraft pilot performance. Am. J. Psychiatry 142, 1325-1329.
44. Yu D. W., Gatley S. J., Wolf A. P., MacGregor R. R., Dewey S. L., Fowler J. S., and Schlyer D. (1992) Synthesis of carbon-11 labeled iodinated cocaine derivatives and their distribution in baboon brain measured using positron emission tomography. J. Med. Chem. 35, 2178-2183.